Funded Startups in Ann Arbor
Among funded Ann Arbor startups with disclosed amounts, ONL Therapeutics’ $65M round (2024-09-13) is the only deal above $50M and it dwarfs the next-larges…
Among funded Ann Arbor startups with disclosed amounts, ONL Therapeutics’ $65M round (2024-09-13) is the only deal above $50M and it dwarfs the next-largest disclosed amount of $40M (Optilogic, 2025-04-08). The disclosed size distribution is also punctuated by a smaller end outlier: Warmilu’s $10K (2023-08-23) sits far below most other disclosed rounds (e.g., $500K–$4M entries like Forever Labs on 2025-10-01 and Tandem on 2024-01-17).
Timing clusters around the most recent edge: the table spans 2022-09-15 to 2026-07-30, with the latest disclosed round being Genomenon’s $6M (2026-07-30) and multiple notable eight-figure rounds in 2024–2025 (ONL Therapeutics in 2024-09-13; Optilogic in 2025-04-08; Amplitude Vascular Systems in 2025-01-28). Sector-wise, Biotechnology appears repeatedly (e.g., Genomenon 2026-07-30 at $6M, ONL Therapeutics 2024-09-13 at $65M, Akadeum Life Sciences 2025-06-03 at $20M), while “Series Unknown” shows up across the list with many disclosed entries (e.g., Heat2Power 2026-04-08 at $15M and SkySpecs 2025-03-19 at $20M).
Most recent rounds
50 of 6313 more funded startups
This page shows the 50 most recent rounds (back to Sep 2022). The full 63-company history for this listing is available on a paid plan.
Unlock all 63 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What’s the largest disclosed round in Ann Arbor on this list, and how does it compare to the rest?
ONL Therapeutics’ $65M (2024-09-13) is the only disclosed round above $50M. The next-largest disclosed amount is $40M for Optilogic (2025-04-08), followed by $36M for Amplitude Vascular Systems (2025-01-28).
Are there clear temporal clusters near the most recent rounds?
Yes—round dates run from 2022-09-15 to 2026-07-30, with the most recent entry being Genomenon at $6M (2026-07-30). The largest disclosed rounds are concentrated in 2024–2025, including ONL Therapeutics ($65M, 2024-09-13), Voxel51 ($30M, 2024-05-16), and Optilogic ($40M, 2025-04-08).
Which sectors appear most often in this Ann Arbor snapshot?
Biotechnology is the most visible sector across multiple companies and dates, including Genomenon ($6M, 2026-07-30), HYGIEIA ($5M, 2023-05-02), and ONL Therapeutics ($65M, 2024-09-13). Energy also recurs (Heat2Power $15M, 2026-04-08; Ecovia Renewables $2M, 2024-12-17).
How dominant is the “Series Unknown” label among disclosed deals?
“Series Unknown” appears frequently alongside disclosed amounts—for example Heat2Power ($15M, 2026-04-08), Akadeum Life Sciences ($20M, 2025-06-03), SkySpecs ($20M, 2025-03-19), and Genomenon ($6M, 2026-07-30). This creates a stage signal gap compared with labeled rounds like Pursuit’s Series A ($22M, 2026-04-29) and ONL Therapeutics’ Series D ($65M, 2024-09-13).
Are there outliers in disclosed round size worth segmenting out?
Warmilu’s $10K (2023-08-23) is the smallest disclosed amount in the set, far below the rest. On the high end, ONL Therapeutics’ $65M (2024-09-13) is a strong positive outlier versus the next-largest disclosed amount of $40M (Optilogic, 2025-04-08).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.